Explained Interview | After obesity and diabetes, where GLP-1 research is headed
Published on: July 15, 2025, 5:35 p.m. | Source: The Indian Express
Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based drugs that have changed how the world sees obesity. Research is on to explore treatment for other conditions, such as Alzheimer's.
